COVID-19 prolongado: ¿un nuevo factor de riesgo para enfermedades autoinmunes y linfoma?

Autores/as

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782-93. DOI: https://doi.org/10.1001/jama.2020.12839

Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74. DOI: https://doi.org/10.1016/j.ebiom.2021.103722

Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10(6):763. DOI: https://doi.org/10.3390/pathogens10060763

Gaspar-Rodríguez A, Padilla-González A, Rivera-Toledo E. Coronavirus persistence in human respiratory tract and cell culture: An overview. The Brazilian Journal of Infectious Diseases. 2021;25(5):101632. DOI: https://doi.org/10.1016/j.bjid.2021.101632

Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):1-7. DOI: https://doi.org/10.1038/s41590-021-01113-x

Schiffner J, Backhaus I, Rimmele J, Schulz S, Möhlenkamp T, Klemens JM, et al. Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection. Front Public Health. 2021;9:732-87. DOI: https://doi.org/10.3389/fpubh.2021.732787

Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for a tailored therapy. European Respiratory Journal. 2021;59(2):2102245. DOI: https://doi.org/10.1183/13993003.02245-2021

Chen J, Dai L, Barrett L, Post SR, Qin Z. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus. Commun Biol. 2021;4(1):682. DOI: https://doi.org/10.1038/s42003-021-02220-z

Shannon-Lowe C, Rickinson AB, Bell AI. Epstein–Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160271. DOI: https://doi.org/10.1098/rstb.2016.0271

Descargas

Publicado

2023-08-13

Cómo citar

1.
Pichardo Rodriguez R, Saavedra Velazco M, Bracamonte Hernández J-J, Córdova-Cueva L, de la Cruz-Vargas JA. COVID-19 prolongado: ¿un nuevo factor de riesgo para enfermedades autoinmunes y linfoma?. Rev Cuba Med Tropical [Internet]. 13 de agosto de 2023 [citado 31 de marzo de 2025];75(1). Disponible en: https://revmedtropical.sld.cu/index.php/medtropical/article/view/1012

Número

Sección

Cartas al editor